The role of histone demethylases in cancer therapy

Area of Science:

• Epigenetics
• Molecular Biology
• Oncology

Background:

• Reversible histone methylation is a critical epigenetic regulatory mechanism.
• Histone methyltransferases and demethylases are implicated in disease development, particularly cancer.
• These enzymes represent promising therapeutic targets for cancer treatment.

Purpose of the Study:

• To review histone demethylases.
• To focus on their potential in oncology drug discovery.
• To provide an overview of enzyme classes, biochemistry, physiological roles, and inhibitors.

Main Methods:

• Literature review of histone demethylases.
• Analysis of enzyme classes and their biochemical properties.
• Examination of physiological roles and existing inhibitors.

Main Results:

• Histone demethylases are diverse enzyme classes.
• Their dysregulation is linked to various cancers.
• Several inhibitors targeting these enzymes are available or in development.

Conclusions:

• Histone demethylases are significant targets for cancer drug discovery.
• Further research into their inhibitors holds therapeutic promise.
• Targeting epigenetic modifications offers a novel approach to cancer therapy.